« Previous
Next »
Titles
- Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules3
- Letter from Paul Berg to Daniel Nathans3
- Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes2
- Letter from Daniel Nathans to Paul Berg2
- 42 CFR Part 66 : Grants -- Regional Medical Programs1
- A Scientific Breakthrough [Editorial]1
- A Statement1
- A Study of the Regional Medical Program: Volume II, Historical Background, Regionalization, Facilitation, Evaluation, Relationships1
- A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research1
- A randomized trial testing the effect of narrative vignettes versus guideline summaries on provider response to a professional organization clinical policy for safe opioid prescribing1
- Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters1
- Appendix C: Program of the International Conference on Recombinant DNA Molecules1
- Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms1
- Appendix F: Cloned Eukaryotic DNA1
- Appendix H: Provisional Statement of the Conference Proceedings1
- Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines1
- Automated Research and Development and other Major Equipment Investments in a Regional Medical Program : Guide to Project Review1
- CT contrast media power injectors can rupture conventional IV sets1
- Containment1
- Coronary Care1